戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lla (MMR) vaccine, which contains genotype A mumps vaccine.
2 uals were adults who had received 2 doses of mumps vaccine.
3 of 18 and 24 years had received two doses of mumps vaccine.
4 ing of virus seeds used in the production of mumps vaccines.
5 uence variations in mixed virus cultures and mumps vaccines.
6 ntly in all chicken cell-derived measles and mumps vaccines.
7               One hurdle in developing a new mumps vaccine against circulating genotype G virus is wh
8       The widespread use of a second dose of mumps vaccine among U.S. schoolchildren beginning in 199
9 haracterize B and T cell immune responses to mumps vaccine and to develop strategies to improve the q
10 icating that it is a promising candidate for mumps vaccine development.
11         This outbreak raises questions about mumps vaccine effectiveness and potential waning immunit
12 esponses in human serum samples from the pre-mumps vaccine era.
13  United States heightened concerns regarding mumps vaccine failure.
14 derstanding of, and possibly for preventing, mumps vaccine failure.We identified for the first time 4
15 investigated the origin of RT in measles and mumps vaccines from a U.S. manufacturer and confirm the
16      The persistence of cellular immunity to mumps vaccine has not been defined.
17 ted mumps viruses used in the manufacture of mumps vaccines have neurovirulent properties, a monkey n
18 f RT activity in all RT-positive measles and mumps vaccines may not be similar and depend on the part
19                             A more effective mumps vaccine or changes in vaccine policy may be needed
20                                              Mumps vaccines prepared from the Jeryl Lynn strain typic
21 euroattenuation and neurovirulence, ensuring mumps vaccine safety has proven problematic, as demonstr
22 nt studies of chick cell-derived measles and mumps vaccines show evidence of two types of retrovirus
23 ) activity in chick cell-derived measles and mumps vaccines showed this activity to be associated wit
24  induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralized the outbrea
25 6, 9, or 12 months to respond to measles and mumps vaccines was evaluated by measuring T cell prolife